US Physical Therapy (USPH) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The 2025 Annual Meeting is scheduled for May 20, 2025, with proposals for electing eight directors, an advisory vote on executive compensation, and ratification of Grant Thornton LLP as auditor.
Shareholders of record as of March 25, 2025, are eligible to vote, with one vote per share; a majority quorum is required.
Proxy materials are available online and by mail, and shareholders are encouraged to vote even if not attending in person.
Voting matters and shareholder proposals
Proposals include electing eight directors, approving executive compensation (say-on-pay), and ratifying Grant Thornton LLP as auditor for 2025.
The board recommends voting in favor of all proposals.
No shareholder nominations were received for this meeting; procedures for 2026 proposals are outlined.
Board of directors and corporate governance
The board will consist of eight directors, six of whom are independent under NYSE standards.
Board leadership includes a combined Chairman/CEO role and a Lead Independent Director.
Four standing committees: Audit, Compensation, Compliance, and Governance/Nominating, all chaired by independent directors.
Board diversity policy emphasizes inclusion of women and people of color in candidate pools.
Recent director appointments have increased board diversity; three most recent appointees are female.
Latest events from US Physical Therapy
- Record 2025 growth and new alliances position for higher 2026 EBITDA and continued expansion.USPH
Q4 20259 Mar 2026 - Double-digit growth and high-margin expansion in injury prevention drive strong performance.USPH
16th Annual Midwest Ideas Conference3 Feb 2026 - Record patient volumes and IIP growth drove revenue up, but margins and EPS declined.USPH
Q2 20241 Feb 2026 - Growth continues via partnerships, acquisitions, and injury prevention despite reimbursement headwinds.USPH
15th Annual Midwest IDEAS Investor Conference23 Jan 2026 - Record patient volumes, 12% revenue growth, and major acquisitions drive future expansion.USPH
Q3 202416 Jan 2026 - Growth through strategic acquisitions and partnerships drives strong performance and expansion.USPH
2024 Southwest IDEAS Conference13 Jan 2026 - Record revenue and patient growth drive higher earnings and positive 2025 outlook.USPH
Q4 202430 Dec 2025 - Record Q2 growth, raised 2025 guidance, and capital returns highlight strong performance.USPH
Q2 202523 Nov 2025 - Record Q1 revenue and earnings growth driven by acquisitions and strong patient volume.USPH
Q1 202519 Nov 2025